Searched for
CEPHALOSPORIN
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Venus Remedies gets Ukrainian GMP renewal certificationVenus Remedies has received renewed GMP certification from Ukraine. This certification applies to its Baddi facility. It covers cephalospor...
- Orchid Pharma shares in focus as U.S. FDA completes facility inspectionOrchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosp...
- Orchid Pharma enter tech transfer pact to make key cephalosporin intermediateChennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7AC...
- Soaring high: Lincoln Pharmaceuticals maintains a solid growth trajectoryLincoln Pharma expects Rs 150 crore in sales from the recently-acquired Cephalosporin plant.
- Divi’s, Gland, Fidelity enter race to buy Orchid PharmaThe move comes even as Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over ...
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...
- Environmental lobby groups blame production methods of drug companies for rise in drug-resistant bacteriaThe Pharmaceuticals Export Council of India (Pharmexcil) set up by the Ministry of Commerce and Industry under foreign trade policy on Thur...
- German ban on Ranbaxy's Dewas product expands to entire EUAdding to Ranbaxy's regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member coun...
- USFDA lifts import alert on Aurobindo Pharma's Hyderabad facilityUSFDA has lifted the import alert for non-sterile products manufactured at Unit-VI cephalosporin facility based in Hyderabad.
- Orchid Pharma receives US FDA approval for Naratriptan tabletsOrchid Chemicals & Pharmaceuticals Ltd today announced that it has received approval from US FDA for its ANDA for Naratriptan tablets.
- Aurobindo Pharma posts Rs 80.16 cr loss in Q2Aurobindo Pharma today posted a consolidated net loss of Rs 80.16 crore for the second quarter ended September 30, 2011.
- Aurobindo Pharma forms JV with Russian Ojsc Diod for generic productsAurobindo Pharma on Wednesday said it has formed an equal joint venture with Russian healthcare equipment company Ojsc Diod.
- Orchid Chemicals, Pharmaceuticals Ltd clear USFDA inspectionOrchid Chemicals and Pharmaceuticals Ltd has said its Cephalosporin API manufacturing (antibiotic) complex in Alathur, Chennai, has success...
- Venus Remedies gets DCGI nod for CephalosporinVenus Remedies on Tuesday said it has got approval from Drug Controller General of India to launch Cephalosporin, used in the treatment of ...
- Orchid gets USFDA nod for CefdinirDrug maker Orchid Chemicals and Pharmaceuticals on Friday said it has received USFDA approval for its antibiotic Cefdinir.
- Wockhardt gets US nod for Cefprozil tabsPharma company Wockhardt Ltd on Wednesday said it has received US Food and Drug Administration (USFDA) approval for Cefprozil tablets, an a...
- Lupin gets US nod for CefdinirLupin Ltd on Friday said it has received the approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Cefdinir Suspensio...
Load More
